CL2016003219A1 - Desmopresina estabilizada - Google Patents
Desmopresina estabilizadaInfo
- Publication number
- CL2016003219A1 CL2016003219A1 CL2016003219A CL2016003219A CL2016003219A1 CL 2016003219 A1 CL2016003219 A1 CL 2016003219A1 CL 2016003219 A CL2016003219 A CL 2016003219A CL 2016003219 A CL2016003219 A CL 2016003219A CL 2016003219 A1 CL2016003219 A1 CL 2016003219A1
- Authority
- CL
- Chile
- Prior art keywords
- desmopressin
- stabilized
- stabilized desmopressin
- film
- gum
- Prior art date
Links
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 title abstract 2
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 title abstract 2
- 229960004281 desmopressin Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020140073067A KR20150144209A (ko) | 2014-06-16 | 2014-06-16 | 안정화된 데스모프레신 또는 이의 약학적으로 허용가능한 염을 함유 약학 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2016003219A1 true CL2016003219A1 (es) | 2017-06-30 |
Family
ID=53510836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2016003219A CL2016003219A1 (es) | 2014-06-16 | 2016-12-15 | Desmopresina estabilizada |
Country Status (33)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114432424B (zh) * | 2021-12-27 | 2023-06-27 | 南通联亚药业股份有限公司 | 一种稳定的铝塑包装去氨加压素片剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE60941B1 (en) * | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
| GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| DE60307082D1 (de) * | 2002-05-07 | 2006-09-07 | Ferring Bv | In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin |
| WO2007083323A2 (en) * | 2006-01-23 | 2007-07-26 | Panacea Biotec Limited. | Modified release oral dosage form comprising desmopressin |
| CN100463674C (zh) * | 2006-12-22 | 2009-02-25 | 江苏奥赛康药业有限公司 | 一种氯雷他定口腔速溶膜及其制备方法 |
| US20150306170A1 (en) * | 2012-11-21 | 2015-10-29 | Ferring B.V. | Composition for immediate and extended release |
| TW201422254A (zh) * | 2012-11-21 | 2014-06-16 | Ferring Bv | 用於速釋及延釋的組成物 |
-
2014
- 2014-06-16 KR KR1020140073067A patent/KR20150144209A/ko active Pending
-
2015
- 2015-06-15 MX MX2016016635A patent/MX374540B/es active IP Right Grant
- 2015-06-15 WO PCT/EP2015/063347 patent/WO2015193246A1/en not_active Ceased
- 2015-06-15 CN CN201580032230.9A patent/CN106456706B/zh active Active
- 2015-06-15 SG SG10201811139UA patent/SG10201811139UA/en unknown
- 2015-06-15 TN TN2016000561A patent/TN2016000561A1/en unknown
- 2015-06-15 ES ES15734080T patent/ES2751600T3/es active Active
- 2015-06-15 EA EA201692556A patent/EA032834B1/ru not_active IP Right Cessation
- 2015-06-15 US US15/318,683 patent/US20170128521A1/en not_active Abandoned
- 2015-06-15 DK DK15734080.3T patent/DK3154516T3/da active
- 2015-06-15 NZ NZ727388A patent/NZ727388A/en unknown
- 2015-06-15 RS RSP20191285 patent/RS59449B1/sr unknown
- 2015-06-15 PT PT157340803T patent/PT3154516T/pt unknown
- 2015-06-15 CA CA2951768A patent/CA2951768C/en active Active
- 2015-06-15 PL PL15734080T patent/PL3154516T3/pl unknown
- 2015-06-15 SI SI201530936T patent/SI3154516T1/sl unknown
- 2015-06-15 EP EP15734080.3A patent/EP3154516B1/en active Active
- 2015-06-15 AU AU2015276247A patent/AU2015276247C1/en active Active
- 2015-06-15 MY MYPI2016704613A patent/MY182781A/en unknown
- 2015-06-15 UA UAA201700344A patent/UA119776C2/uk unknown
- 2015-06-15 HR HRP20191746TT patent/HRP20191746T1/hr unknown
- 2015-06-15 SG SG11201609374YA patent/SG11201609374YA/en unknown
- 2015-06-15 LT LT15734080T patent/LT3154516T/lt unknown
- 2015-06-15 HU HUE15734080A patent/HUE045395T2/hu unknown
- 2015-06-15 KR KR1020177001134A patent/KR102360656B1/ko active Active
- 2015-06-15 JP JP2016573603A patent/JP6615130B2/ja active Active
- 2015-06-16 AR ARP150101907A patent/AR100850A1/es not_active Application Discontinuation
- 2015-06-16 TW TW104119405A patent/TWI670070B/zh active
- 2015-06-16 JO JOP/2015/0148A patent/JO3500B1/ar active
-
2016
- 2016-11-18 ZA ZA2016/08020A patent/ZA201608020B/en unknown
- 2016-12-13 IL IL249538A patent/IL249538A0/en unknown
- 2016-12-13 SA SA516380492A patent/SA516380492B1/ar unknown
- 2016-12-15 CL CL2016003219A patent/CL2016003219A1/es unknown
- 2016-12-16 PH PH12016502527A patent/PH12016502527B1/en unknown
-
2017
- 2017-01-16 CO CONC2017/0000354A patent/CO2017000354A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016002772A1 (es) | Composiciones de insulina de rápida acción | |
| MX2018000412A (es) | Moduladores de diaciglicerol aciltransferasa 2 (dgat2). | |
| BR112017022089A2 (pt) | uso de uma composição, e, método para branqueamento de dentes | |
| MX2017001512A (es) | Compuestos activos hacia bromodominios. | |
| HUE046272T2 (hu) | Készítmények és eljárások a komplement B-faktor expressziójának modulálására | |
| UY36703A (es) | Composiciones y métodos para la administración de un polinucleótido en una planta | |
| CL2016002560A1 (es) | Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación. | |
| CL2017002214A1 (es) | Formulación de combinación de tesofensina y betabloqueante | |
| MX2017011655A (es) | Compuestos de aza-piridona y usos de estos. | |
| CL2016002197A1 (es) | Estructura de prótesis para implante dental | |
| EA201790650A1 (ru) | Лекарственная форма и способы применения абиратерона ацетата | |
| CL2017001647A1 (es) | Composicion protectora solar | |
| CL2018003826A1 (es) | Uso de una fracción lignina como un agente anti fitopatogenico y composiciones fitopatogenicas conteniendo dicho agente. | |
| CL2017000152A1 (es) | Derivados de isoindolinona | |
| BR112017007753A2 (pt) | uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico. | |
| CL2017000244A1 (es) | Formulaciones de compuestos biológicos para instilación intravesical. | |
| CL2016003023A1 (es) | “compuestos derivados de (bencil-piperazin-1-il)(tetrahidrofuran-carbonil o tetrahidropiran-carbonil) sustituido, moduladores rorg; composición farmacéutica que los comprende; y su uso en el tratamiento de la esclerosis múltiple y espondilitis anquilosante”. pct | |
| MX2017007420A (es) | Composiciones para el cuidado bucal con alto contenido de agua y micro resistencia. | |
| CL2016002391A1 (es) | Ensamble de filtro. | |
| JOP20200126B1 (ar) | طرق استخدام وتركيبات تحتوي على دولاجلوتيد | |
| MX2016015106A (es) | Derivados de dipicolilamina y sus usos farmaceuticos. | |
| MX2019005557A (es) | Composicion para el cuidado bucal. | |
| MX2019005495A (es) | Composicion para el cuidado bucal. | |
| BR112016026470A2 (pt) | Composto modulador de hsp70, composição farmacêutica que o compreende e uso do referido composto | |
| CO2017001076A2 (es) | Composiciones farmacéuticas antihiperalgésicas, antialodínicas y antiinflamatorias que contienen pregabalina y meloxicam |